- Luellen BA. Bianco LE. Schneider LM. Andrews AM. Reduced brain-derived neurotrophic factor is associated with a loss of serotonergic innervation in the hippocampus of aging mice. 2007 Jul. Genes Brain Behav. 6(5):482-90.
|
- Luellen BA. Szapacs ME. Materese CK. Andrews AM. The neurotoxin 2'-NH2-MPTP degenerates serotonin axons and evokes increases in hippocampal BDNF. 2006 Mar. Neuropharmacology. 50(3):297-308.
National Institute of Mental Health |
- Perez XA. Bianco LE. Andrews AM. Filtration disrupts synaptosomes during radiochemical analysis of serotonin uptake: comparison with chronoamperometry in SERT knockout mice. 2006 Jun 30. J Neurosci Methods. 154(1-2):245-55.
National Institute of Mental Health |
- Unger EL. Eve DJ. Perez XA. Reichenbach DK. Xu Y. Lee MK. Andrews AM. Locomotor hyperactivity and alterations in dopamine neurotransmission are associated with overexpression of A53T mutant human alpha-synuclein in mice. 2006 Feb. Neurobiol Dis. 21(2):431-43.
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke |
- Counterman AE. D'Onofrio TG. Andrews AM. Weiss PS. A physical model of axonal damage due to oxidative stress. 2006 Apr 4. Proc Natl Acad Sci U S A. 103(14):5262-6.
|
- Perez XA. Andrews AM. Chronoamperometry to determine differential reductions in uptake in brain synaptosomes from serotonin transporter knockout mice. 2005 Feb 1. Anal Chem. 77(3):818-26.
National Institute of Mental Health |
- Numis AL. Unger EL. Sheridan DL. Chisnell AC. Andrews AM. The role of membrane and vesicular monoamine transporters in the neurotoxic and hypothermic effects of 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine (2'-NH(2)-MPTP). 2004 Sep. Mol Pharmacol. 66(3):718-27.
National Institute of Mental Health |
- Szapacs ME. Mathews TA. Tessarollo L. Ernest Lyons W. Mamounas LA. Andrews AM. Exploring the relationship between serotonin and brain-derived neurotrophic factor: analysis of BDNF protein and extraneuronal 5-HT in mice with reduced serotonin transporter or BDNF expression. 2004 Dec 30. J Neurosci Methods. 140(1-2):81-92.
National Institute of Mental Health |
- Mathews TA. Fedele DE. Coppelli FM. Avila AM. Murphy DL. Andrews AM. Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression. 2004 Dec 30. J Neurosci Methods. 140(1-2):169-81.
National Institute of Mental Health |
- Szapacs ME. Numis AL. Andrews AM. Late onset loss of hippocampal 5-HT and NE is accompanied by increases in BDNF protein expression in mice co-expressing mutant APP and PS1. 2004 Aug. Neurobiol Dis. 16(3):572-80.
National Institute of Mental Health |
- Luellen BA. Miller DB. Chisnell AC. Murphy DL. O'Callaghan JP. Andrews AM. Neuronal and astroglial responses to the serotonin and norepinephrine neurotoxin: 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine. 2003 Dec. J Pharmacol Exp Ther. 307(3):923-31.
National Institute of Mental Health |
- Unger EL. Mazzola-Pomietto P. Murphy DL. Andrews AM. 2'-NH(2)-MPTP [1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine] depletes serotonin and norepinephrine in rats: a comparison with 2'-CH(3)-MPTP [1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine]. 2002 Nov. J Pharmacol Exp Ther. 303(2):527-33.
|
